A brief report: absence of elevated circulating NETosis markers in long-term long COVID
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1920533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Bart Humer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Erasmus Medical Center, Rotterdam, Netherlands. Hauptthemen laut MEDLINE: Extracellular Traps, COVID-19, Biomarkers. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Neutrophil extracellular trap (NET) formation (NETosis) has been proposed as a contributor to the pathophysiology of Long COVID (LC). However, it remains unclear whether markers of systemic NETosis remain elevated in individuals with persistent symptoms years after the initial infection.
Methods
To assess NETosis, we quantified MPO-DNA, Histone DNA, and Citrullinated H3 levels in the plasma of 51 patients with prolonged LC (mean disease duration of three years), and compared them with 52 age- and sex-matched healthy controls.
Results
No significant differences were observed between participants with LC and healthy controls for any of the three NETosis markers. Hierarchical clustering reveals no specific subgroups in the patient group. Furthermore, NETosis marker levels were not associated with overall symptom burden or individual symptom domains.
Conclusions
In this cohort of individuals with long-term LC, we found no evidence of persistent systemic NETosis. These findings suggest that elevated circulating NETosis markers are not a universal feature of long-term LC and may indicate that neutrophil activation observed during acute or early post-acute disease does not persist in long-term disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Erasmus Medical Center, Rotterdam, Netherlands.
- Department of Hematology, Erasmus Medical Center, Rotterdam, Netherlands.
- Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
- Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands.
- Department of Intensive Care, Elisabeth-TweeSteden Hospital, Tilburg, Netherlands.
Zitieren
APA
Humer, B., Eyisoylu, H., Berentschot, J. C., Bek, L. M., Boly, C. A., Hellemons, M. E., & de Maat, M. P. M. (2026). A brief report: absence of elevated circulating NETosis markers in long-term long COVID. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1920533
Vancouver
Humer B, Eyisoylu H, Berentschot JC, Bek LM, Boly CA, Hellemons ME, et al. A brief report: absence of elevated circulating NETosis markers in long-term long COVID. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1920533
BibTeX
@article{Humer2026,
author = {Humer, Bart and Eyisoylu, Hande and Berentschot, Julia C and Bek, L Martine and Boly, Chantal A and Hellemons, Merel E and de Maat, Moniek P M},
title = {A brief report: absence of elevated circulating NETosis markers in long-term long COVID},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1920533}
}
EUVIMED